Original Research

Sertaconazole Nitrate Cream 2% for the Treatment of Tinea Pedis

Tinea pedis, both in its acute and chronic phase, is a common skin condition that often is overlooked but can lead to onychomycosis and acute bacterial cellulitis if left untreated. Therefore, aggressive treatment with a topical antifungal agent is warranted. Sertaconazole nitrate cream 2% is a newer imidazole agent that possesses both fungicidal and fungistatic properties to eradicate existing infections. In addition to antifungal properties, it exhibits anti-inflammatory and antipruritic effects. Controlled clinical trials have confirmed its safety, tolerability, and efficacy in participants with tinea pedis. We report 2 patients with chronic tinea pedis of many years’ duration and demonstrate the usefulness of sertaconazole nitrate cream 2% in the clinical setting. Tinea pedis was confirmed by results of a potassium hydroxide preparation. Both patients experienced marked improvement by the second week of twice-daily treatment with sertaconazole nitrate cream 2%. Clinical cure was achieved in both patients. These findings suggest that sertaconazole nitrate cream 2% is an effective option for the treatment of tinea pedis.


 

Recommended Reading

Military Personnel Returning With Drug-Resistant Pathogen
MDedge Dermatology
Despite Prevention Efforts, STDs Are on the Rise
MDedge Dermatology
Keeping Children Home Is Often Not Justified
MDedge Dermatology
Multiple Factors Linked to Antibiotic Resistance
MDedge Dermatology
Varicella Vaccine Not Tied to Stroke, Study Finds
MDedge Dermatology
Expert Reviews Outpatient Treatment Options for MRSA
MDedge Dermatology
Gardasil Prevents Warts, HPV Infection in Males
MDedge Dermatology
New Smallpox Vaccine Found Safer Than Existing Vaccines
MDedge Dermatology
HPV Misunderstood, Feared In One Border Community
MDedge Dermatology
What Is Your Diagnosis? Acute Herpes Simplex Virus Type 1 Stomatitis
MDedge Dermatology